Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives-Reference-Cited by-同舟云学术

Global Vaccine Action Plan Lessons Learned II: Stakeholder Perspectives

Published:2020-07 Issue:33 Volume:38 Page:5372-5378
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Hwang Angela^ORCID,Veira Chantal,Malvolti Stefano^ORCID,Cherian Thomas^ORCID,MacDonald Noni,Steffen Christoph,Jones Ian,Hinman Alan,Mantel Carsten

Funder

Bill & Melinda Gates Foundation

WHO

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference13 articles.

1. World Health Organization. Global Vaccine Action Plan 2011-2020. WHO Press, 2013. http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/ [accessed February 14, 2019].

2. UN Inter-agency Group for Child Mortality Estimation. Levels & Trends in Child Mortality Report 2019. United Nations Children's Fund, 2019. https://childmortality.org/wp-content/uploads/2019/10/UN-IGME-Child-Mortality-Report-2019.pdf [accessed December 4, 2019].

3. World Health Organization Strategic Advisory Group of Experts on Immunization. The Global Vaccine Action Plan 2011-2020 Review and Lessons Learned. 2019. https://apps.who.int/iris/bitstream/handle/10665/329097/WHO-IVB-19.07-eng.pdf [accessed November 19, 2019].

4. World Health Organization Strategic Advisory Group of Experts on Immunization. 2018 Assessment Report of the Global Vaccine Action Plan. 2018. https://apps.who.int/iris/bitstream/handle/10665/276967/WHO-IVB-18.11-eng.pdf?ua=1 [accessed August 20, 2019].

5. MacDonald N, Mohsni E, Al-Mazrou Y, Andrus JK, Arora N, Elden S, et al. Global Vaccine Action Plan Review and Lessons Learned I: Recommendations for the Next Decade. Vaccine 2020;38:5364–71. http://dx.doi.org/10.1016/j.vaccine.2020.05.003.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing;International Journal of Biological Macromolecules;2024-10

2. Insufficient vaccination coverage in children with severe neurological pathology: causes and consequences;Russian Pediatric Journal;2024-07-12

3. Regulatory processes involved in clinical trials and intellectual property rights around vaccine development;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Critical success factors for high routine immunisation performance: a qualitative analysis of interviews and focus groups from Nepal, Senegal, and Zambia;BMJ Open;2023-10

5. Critical interventions for demand generation in Zambia, Nepal, and Senegal with regards to the 5C psychological antecedents of vaccination;Vaccine: X;2023-08